John C. Burnett, Ph.D. - Publications

Affiliations: 
2002-2008 Chemical Engineering University of California, Berkeley, Berkeley, CA 
 2008-2017 Molecular and Cellular Biology Beckman Research Institute of City of Hope, Monrovia, CA, United States 
 2017- Center for Gene Therapy Beckman Research Institute of City of Hope, Monrovia, CA, United States 
Area:
viral gene delivery, stem cells, HIV
Website:
https://cal.berkeley.edu/burnett

273 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Alexander SP, Fabbro D, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Beuve A, Brouckaert P, Bryant C, ... Burnett JC, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors. British Journal of Pharmacology. 178: S264-S312. PMID 34529829 DOI: 10.1111/bph.15541  1
2021 Wan SH, McKie PM, Slusser JP, Burnett JC, Hodge DO, Chen HH. Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction. Physiological Reports. 9: e14974. PMID 34405565 DOI: 10.14814/phy2.14974  1
2021 Petraina A, Nogales C, Krahn T, Mucke H, Lüscher TF, Fischmeister R, Kass DA, Burnett JC, Hobbs AJ, Schmidt HHHW. Cyclic GMP modulating drugs in cardiovascular diseases: Mechanism-based network pharmacology. Cardiovascular Research. PMID 34270705 DOI: 10.1093/cvr/cvab240  0.01
2021 Ma X, Chen Y, Reginauld SH, Scott CG, Iyer SR, Schaefer JJ, Ichiki T, Chen HH, Rule AD, Burnett JC, Sangaralingham SJ. Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure. Jacc. Heart Failure. PMID 34246604 DOI: 10.1016/j.jchf.2021.04.013  1
2021 Cannone V, Ledwidge M, Watson C, McKie PM, Burnett JC, McDonald K. STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure. Jacc. Basic to Translational Science. 6: 497-504. PMID 34222720 DOI: 10.1016/j.jacbts.2021.05.001  1
2021 Setten RL, Chomchan P, Epps EW, Burnett JC, Rossi JJ. CRED9: A differentially expressed elncRNA regulates expression of transcription factor CEBPA. Rna (New York, N.Y.). PMID 34039742 DOI: 10.1261/rna.078752.121  1
2021 Tan NY, Deng Y, Yao X, Sangaralingham LR, Shah ND, Rule AD, Burnett JC, Dunlay SM, Sangaralingham SJ. Renal Outcomes in Patients with Systolic Heart Failure Treated With Sacubitril-Valsartan or Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker. Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 5: 286-297. PMID 33997628 DOI: 10.1016/j.mayocpiqo.2020.10.008  1
2021 Ferrario CM, Iyer SR, Burnett JC, Ahmad S, Wright KN, VonCannon JL, Saha A, Groban L. Angiotensin (1-12) in Humans With Normal Blood Pressure and Primary Hypertension. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA12016. PMID 33461312 DOI: 10.1161/HYPERTENSIONAHA.120.16514  1
2020 Murphy SP, Prescott MF, Camacho A, Iyer SR, Maisel AS, Felker GM, Butler J, Piña IL, Ibrahim NE, Abbas C, Burnett JC, Solomon SD, Januzzi JL. Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. Jacc. Heart Failure. PMID 33189632 DOI: 10.1016/j.jchf.2020.09.013  1
2020 Chen HH, Burnett JC. Neprilysin in HFrEF: Differential Regulation of Tissue Versus Circulating Neprilysin. Jacc. Basic to Translational Science. 5: 727-729. PMID 32760917 DOI: 10.1016/j.jacbts.2020.05.010  1
2020 Hubers SA, Schirger JA, Sangaralingham SJ, Chen Y, Burnett JC, Hodge D, Chen HH. B-type natriuretic peptide and cardiac remodelling after myocardial infarction: a randomised trial. Heart (British Cardiac Society). PMID 32747497 DOI: 10.1136/heartjnl-2020-317182  1
2020 Ramakrishnan V, Burnett JC. Natriuretic Peptides, Inflammation, and Sounding the Alarm. Circulation. Heart Failure. CIRCHEARTFAILURE1200. PMID 32611204 DOI: 10.1161/CIRCHEARTFAILURE.120.007208  0.01
2020 Burnett JC. Vericiguat - Another Victory for Targeting Cyclic GMP in Heart Failure. The New England Journal of Medicine. 382: 1952-1953. PMID 32402167 DOI: 10.1056/NEJMe2006855  0.01
2020 Savira F, Magaye R, Liew D, Reid C, Kelly D, Kompa AR, Sangaralingham SJ, Burnett JC, Kaye D, Wang BH. Cardiorenal Syndrome: Multi-organ Dysfunction Involving the Heart, Kidney and Vasculature. British Journal of Pharmacology. PMID 32250449 DOI: 10.1111/bph.15065  1
2020 Ibrahim NE, Burnett JC, Butler J, Camacho A, Felker GM, Fiuzat M, O'Connor C, Solomon SD, Vaduganathan M, Zile MR, Januzzi JL. Natriuretic Peptides as Inclusion Criteria in Clinical Trials: A JACC Heart Failure Position Paper. Jacc. Heart Failure. PMID 32171762 DOI: 10.1016/j.jchf.2019.12.010  1
2020 Chen Y, Schaefer JJ, Iyer SR, Harders GE, Pan S, Sangaralingham SJ, Chen HH, Redfield MM, Burnett JC. Long-Term Blood Pressure Lowering and cGMP Activating Actions of the Novel ANP Analogue MANP. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. PMID 32022596 DOI: 10.1152/ajpregu.00354.2019  1
2020 Reginauld SH, Burnett JC. Reply: The Role of miRNAs and lncRNAs in ANP Production Downregulation in Heart Failure. Jacc. Heart Failure. 8: 85. PMID 31896422 DOI: 10.1016/j.jchf.2019.11.003  1
2019 Wan SH, Torres-Courchoud I, McKie PM, Slusser JP, Redfield MM, Burnett JC, Hodge DO, Chen HH. Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP. Jacc. Basic to Translational Science. 4: 962-972. PMID 31909303 DOI: 10.1016/j.jacbts.2019.08.008  1
2019 Spannella F, Giulietti F, Bordicchia M, Burnett JC, Sarzani R. Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis. Scientific Reports. 9: 19178. PMID 31844088 DOI: 10.1038/s41598-019-55680-z  1
2019 Hansen LH, Madsen TD, Goth CK, Clausen H, Chen Y, Dzoyashvili N, Iyer SR, Sangaralingham SJ, Burnett JC, Rehfeld JF, Vakhrushev SY, Schjoldager KT, Goetze JP. Correction: Discovery of -glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor. The Journal of Biological Chemistry. 294: 18516. PMID 31784477 DOI: 10.1074/Jbc.Aac119.011661  1
2019 Chen Y, Burnett JC. The Kidney, Bone Marrow, and Heart Connection in Acute Kidney Injury: Role of Galecin-3. Jacc. Basic to Translational Science. 4: 733-735. PMID 31713546 DOI: 10.1016/j.jacbts.2019.09.001  1
2019 Burnett JC, Ma X, McKie PM. Myocardial Aging, the Cardiac Atria, and BNP: What Does it All Mean? Journal of the American College of Cardiology. 74: 1801-1803. PMID 31582140 DOI: 10.1016/j.jacc.2019.08.020  1
2019 Arendse LB, Danser AHJ, Poglitsch M, Touyz RM, Burnett JC, Llorens-Cortes C, Ehlers MR, Sturrock ED. Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure. Pharmacological Reviews. 71: 539-570. PMID 31537750 DOI: 10.1124/Pr.118.017129  0.01
2019 Reginauld SH, Cannone V, Iyer S, Scott C, Bailey K, Schaefer J, Chen Y, Sangaralingham SJ, Burnett JC. Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP. Jacc. Heart Failure. PMID 31521687 DOI: 10.1016/J.Jchf.2019.05.012  1
2019 Lyle MA, Iyer SR, Redfield MM, Reddy YNV, Felker GM, Cappola TP, Hernandez AF, Scott CG, Burnett JC, Pereira NL. Circulating Neprilysin in Patients with Heart Failure with Preserved Ejection Fraction. Jacc. Heart Failure. PMID 31392960 DOI: 10.1016/j.jchf.2019.07.005  1
2019 Burnett JC. Atrial Natriuretic Peptide, Heart Failure and the Heart as an Endocrine Organ. Clinical Chemistry. PMID 31362934 DOI: 10.1373/clinchem.2019.308106  0.01
2019 Reddy YNV, Iyer SR, Scott CG, Rodeheffer RJ, Bailey K, Jenkins G, Batzler A, Redfield MM, Burnett JC, Pereira NL. Soluble Neprilysin in the General Population: Clinical Determinants and Its Relationship to Cardiovascular Disease. Journal of the American Heart Association. 8: e012943. PMID 31345101 DOI: 10.1161/Jaha.119.012943  1
2019 Cannone V, Cabassi A, Volpi R, Burnett JC. Atrial Natriuretic Peptide: A Molecular Target of Novel Therapeutic Approaches to Cardio-Metabolic Disease. International Journal of Molecular Sciences. 20. PMID 31269783 DOI: 10.3390/ijms20133265  1
2019 Hansen LH, Madsen TD, Goth CK, Clausen H, Chen Y, Dzhoyashvili N, Iyer SR, Sangaralingham SJ, Burnett JC, Rehfeld JF, Vakhrushev SY, Schjoldager KT, Goetze JP. Discovery of -glycans on atrial natriuretic peptide (ANP) that affect both its proteolytic degradation and potency at its cognate receptor. The Journal of Biological Chemistry. PMID 31186350 DOI: 10.1074/jbc.RA119.008102  1
2019 Yang S, Huang S, Daniels LB, Yeboah J, Lima JAC, Cannone V, Burnett JC, Beckman JA, Carr JJ, Wang TJ, Gupta DK. NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis. Heart (British Cardiac Society). PMID 31152069 DOI: 10.1136/Heartjnl-2019-314707  1
2019 Chen Y, Zheng Y, Iyer SR, Harders GE, Pan S, Chen HH, Ichiki T, Burnett JC, Sangaralingham SJ. C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts. Journal of Molecular and Cellular Cardiology. PMID 30954448 DOI: 10.1016/j.yjmcc.2019.03.024  1
2019 Chen Y, Harty GJ, Zheng Y, Iyer SR, Sugihara S, Sangaralingham SJ, Ichiki T, Grande JP, Lee HC, Wang XL, Burnett JC. CRRL269: A Novel Particulate Guanylyl Cyclase A Receptor Peptide Activator For Acute Kidney Injury. Circulation Research. PMID 30929579 DOI: 10.1161/CIRCRESAHA.118.314164  1
2019 Sangaralingham SJ, Chen Y, Burnett JC. C-type natriuretic peptide: the heart's guardian angel. European Heart Journal. PMID 30907411 DOI: 10.1093/eurheartj/ehz142  1
2019 Bachmann KN, Huang S, Lee H, Dichtel LE, Gupta DK, Burnett JC, Miller KK, Wang TJ, Finkelstein JS. Effect of Testosterone on Natriuretic Peptide Levels. Journal of the American College of Cardiology. 73: 1288-1296. PMID 30898204 DOI: 10.1016/J.Jacc.2018.12.062  1
2019 Ibrahim NE, McCarthy CP, Shrestha S, Gaggin HK, Mukai R, Szymonifka J, Apple FS, Burnett JC, Iyer S, Januzzi JL. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays. Journal of the American College of Cardiology. 73: 1273-1284. PMID 30898202 DOI: 10.1016/j.jacc.2018.12.063  1
2019 Meems LMG, Andersen IA, Pan S, Harty G, Chen Y, Zheng Y, Harders GE, Ichiki T, Heublein DM, Iyer SR, Sangaralingham SJ, McCormick DJ, Burnett JC. Design, Synthesis, and Actions of an Innovative Bispecific Designer Peptide. Hypertension (Dallas, Tex. : 1979). HYPERTENSIONAHA11812. PMID 30798663 DOI: 10.1161/HYPERTENSIONAHA.118.12012  1
2019 Priceman SJ, Yamaguchi Y, Epps E, Burnett J, Forman SJ. YIA19-005: Immunotherapy for Prostate Cancer Combining CAR-Engineered T Cells with Targeted Immune Checkpoint Inhibition Journal of the National Comprehensive Cancer Network. 17. DOI: 10.6004/Jnccn.2018.7213  0.01
2019 Chen Y, Harty G, Zheng Y, Sugihara S, Iyer S, Sangaralingham J, Ichiki T, Burnett JC. Crrl269 As An Innovative Particulate Guanylyl Cyclase Receptor (Gc-A) Peptide Activator For Acute Kidney Injury Treatment Journal of the American College of Cardiology. 73: 3065. DOI: 10.1016/S0735-1097(19)33671-X  1
2018 Sangaralingham SJ, Burnett JC. Relaxing With C-Type Natriuretic Peptide, the Guanylyl Cyclase B Receptor, and Pericytes. Circulation. 138: 509-512. PMID 30571536 DOI: 10.1161/CIRCULATIONAHA.118.035132  1
2018 Oatmen KE, Zile MR, Burnett JC, Spinale FG. Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review. Jama Cardiology. PMID 30484834 DOI: 10.1001/Jamacardio.2018.3789  0.01
2018 Cannone V, Buglioni A, Sangaralingham SJ, Scott C, Bailey KR, Rodeheffer R, Redfield MM, Sarzani R, Burnett JC. Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population. Mayo Clinic Proceedings. 93: 980-990. PMID 30077215 DOI: 10.1016/j.mayocp.2018.05.027  1
2018 Ichiki T, Dzhoyashvili N, Burnett JC. Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide. International Journal of Cardiology. PMID 29941213 DOI: 10.1016/j.ijcard.2018.06.002  1
2018 Arizala JA, Takahashi M, Burnett JC, Ouellet DL, Rossi JJ. Nucleolar Localization of HIV-1 Rev is Required Yet Insufficient for Production of Infectious Viral Particles. Aids Research and Human Retroviruses. PMID 29804468 DOI: 10.1089/Aid.2017.0306  1
2018 Chen Y, Burnett JC. Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications. International Journal of Molecular Sciences. 19. PMID 29584705 DOI: 10.3390/ijms19041006  1
2018 Satheesan S, Li H, Burnett JC, Takahashi M, Li S, Wu SX, Synold TW, Rossi JJ, Zhou J. HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART. Journal of Virology. PMID 29343582 DOI: 10.1128/Jvi.02118-17  1
2017 Cannone V, Scott CG, Decker PA, Larson NB, Palmas W, Taylor KD, Wang TJ, Gupta DK, Bielinski SJ, Burnett JC. A favorable cardiometabolic profile is associated with the G allele of the genetic variant rs5068 in African Americans: The Multi-Ethnic Study of Atherosclerosis (MESA). Plos One. 12: e0189858. PMID 29253899 DOI: 10.1371/Journal.Pone.0189858  1
2017 Kawakami R, Lee CYW, Scott C, Bailey KR, Schirger JA, Chen HH, Benike SL, Cannone V, Martin FL, Sangaralingham SJ, Ichiki T, Burnett JC. A human study to evaluate safety, tolerability and cyclic gmp activating properties of cenderitide in subjects with stable chronic heart failure. Clinical Pharmacology and Therapeutics. PMID 29226471 DOI: 10.1002/cpt.974  1
2017 Chen Y, Harty GJ, Huntley BK, Iyer SR, Heublein DM, Harders GE, Meems LMG, Pan S, Sangaralingham SJ, Ichiki T, Burnett JC. CRRL269: A Novel Designer and Renal Enhancing pGC-A Peptide Activator. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00286.2017. PMID 29187381 DOI: 10.1152/ajpregu.00286.2017  1
2017 Gupta DK, Daniels LB, Cheng S, deFilippi CR, Criqui MH, Maisel AS, Lima JA, Bahrami H, Greenland P, Cushman M, Tracy R, Siscovick D, Bertoni AG, Cannone V, Burnett JC, et al. Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis). The American Journal of Cardiology. PMID 28750825 DOI: 10.1016/J.Amjcard.2017.06.030  1
2017 Sugihara S, Burnett JC. BLAST-AHF: insights into biased AT1 ligands and heart failure. Beginning of the end or end of the beginning? European Heart Journal. PMID 28575396 DOI: 10.1093/eurheartj/ehx276  1
2017 Ichiki T, Burnett JC. Atrial Natriuretic Peptide - Old But New Therapeutic in Cardiovascular Diseases. Circulation Journal : Official Journal of the Japanese Circulation Society. PMID 28552863 DOI: 10.1253/circj.CJ-17-0499  1
2017 Saiki H, Moulay G, Guenzel AJ, Liu W, Decklever T, Classic K, Pham L, Chen HH, Burnett JC, Russell SJ, Redfield MM. Experimental Cardiac Radiation Exposure Induces Ventricular Diastolic Dysfunction with Preserved Ejection Fraction. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00124.2017. PMID 28550173 DOI: 10.1152/Ajpheart.00124.2017  1
2017 Ichiki T, Huntley BK, Harty GJ, Sangaralingham SJ, Burnett JC. Early activation of deleterious molecular pathways in the kidney in experimental heart failure with atrial remodeling. Physiological Reports. 5. PMID 28507167 DOI: 10.14814/phy2.13283  1
2017 Glöde A, Naumann J, Gnad T, Cannone V, Kilic A, Burnett JC, Pfeifer A. Divergent effects of a designer natriuretic peptide CD-NP in the regulation of adipose tissue and metabolism. Molecular Metabolism. 6: 276-287. PMID 28271034 DOI: 10.1016/j.molmet.2016.12.010  1
2017 Ichiki T, Burnett JC, Scott CG, Heublein DM, Miyata M, Kinugawa K, Inoue T, Tei C. Neurohumoral Modulation During Waon Therapy in Chronic Heart Failure - Subanalysis of Waon-CHF Study. Circulation Journal : Official Journal of the Japanese Circulation Society. PMID 28202884 DOI: 10.1253/circj.CJ-16-1117  1
2017 Chen Y, Burnett JC. Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease. Clinical Chemistry. 63: 108-115. PMID 28062615 DOI: 10.1373/clinchem.2016.262907  1
2016 Meems LMG, Burnett JC. Innovative Therapeutics: Designer Natriuretic Peptides. Jacc. Basic to Translational Science. 1: 557-567. PMID 28497128 DOI: 10.1016/j.jacbts.2016.10.001  0.01
2016 McKie PM, Burnett JC. NT-proBNP: The Gold Standard Biomarker in Heart Failure. Journal of the American College of Cardiology. 68: 2437-2439. PMID 27908348 DOI: 10.1016/j.jacc.2016.10.001  1
2016 AbouEzzeddine OF, McKie PM, Scott CG, Rodeheffer RJ, Chen HH, Michael Felker G, Jaffe AS, Burnett JC, Redfield MM. Biomarker-based risk prediction in the community. European Journal of Heart Failure. 18: 1342-1350. PMID 27813304 DOI: 10.1002/ejhf.663  1
2016 Takahashi M, Wu X, Ho M, Chomchan P, Rossi JJ, Burnett JC, Zhou J. High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency. Scientific Reports. 6: 33697. PMID 27652575 DOI: 10.1038/Srep33697  1
2016 Dao P, Hoinka J, Takahashi M, Zhou J, Ho M, Wang Y, Costa F, Rossi JJ, Backofen R, Burnett J, Przytycka TM. AptaTRACE Elucidates RNA Sequence-Structure Motifs from Selection Trends in HT-SELEX Experiments. Cell Systems. 3: 62-70. PMID 27467247 DOI: 10.1016/J.Cels.2016.07.003  1
2016 Lee CY, Huntley BK, McCormick DJ, Ichiki T, Sangaralingham SJ, Lisy O, Burnett JC. Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions. European Heart Journal. Cardiovascular Pharmacotherapy. 2: 98-105. PMID 27340557 DOI: 10.1093/ehjcvp/pvv040  1
2016 Holditch SJ, Schreiber CA, Burnett JC, Ikeda Y. Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females. Scientific Reports. 6: 25623. PMID 27162120 DOI: 10.1038/srep25623  1
2016 Bordicchia M, Ceresiani M, Pavani M, Minardi D, Polito M, Wabitsch M, Cannone V, Burnett JC, Dessi-Fulgheri P, Sarzani R. Insulin/Glucose Induces Natriuretic Peptide Clearance Receptor in Human Adipocytes: a Metabolic Link With the Cardiac Natriuretic Pathway. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. ajpregu.00499.2015. PMID 27101299 DOI: 10.1152/ajpregu.00499.2015  1
2016 Hiemstra JA, Lee DI, Chakir K, Gutiérrez-Aguilar M, Marshall KD, Zgoda PJ, Cruz Rivera N, Dozier DG, Ferguson BS, Heublein DM, Burnett JC, Scherf C, Ivey JR, Minervini G, McDonald KS, et al. Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine. Journal of the American Heart Association. 5. PMID 27098966 DOI: 10.1161/Jaha.116.003277  1
2016 Grupper A, Zhao YM, Sajgalik P, Joyce LD, Park SJ, Pereira NL, Stulak JM, Burnett JC, Edwards BS, Daly RC, Kushwaha SS, Schirger JA. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation. The American Journal of Cardiology. PMID 27079215 DOI: 10.1016/j.amjcard.2016.03.011  1
2016 Wan SH, McKie PM, Schirger JA, Slusser JP, Hodge DO, Redfield MM, Burnett JC, Chen HH. Chronic Peptide Therapy With B-Type Natriuretic Peptide in Patients With Preclinical Diastolic Dysfunction (Stage B Heart Failure). Jacc. Heart Failure. PMID 26874387 DOI: 10.1016/j.jchf.2015.12.014  1
2016 McKie PM, Schirger JA, Benike SL, Harstad LK, Slusser JP, Hodge DO, Redfield MM, Burnett JC, Chen HH. Chronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure. European Journal of Heart Failure. PMID 26806605 DOI: 10.1002/ejhf.468  1
2016 Sangaralingham SJ, Wang BH, Huang L, Kumfu S, Ichiki T, Krum H, Burnett JC. Cardiorenal Fibrosis and Dysfunction in Aging: Imbalance in Mediators and Regulators of Collagen. Peptides. PMID 26774586 DOI: 10.1016/j.peptides.2016.01.004  1
2016 Jung U, Takahashi M, Rossi JJ, Burnett JC. LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds. Methods in Molecular Biology (Clifton, N.J.). 1354: 255-64. PMID 26714717 DOI: 10.1007/978-1-4939-3046-3_17  1
2015 Buglioni A, Cannone V, Sangaralingham SJ, Heublein DM, Scott CG, Bailey KR, Rodeheffer RJ, Sarzani R, Burnett JC. Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up. Journal of the American Heart Association. 4. PMID 26702078 DOI: 10.1161/Jaha.115.002505  1
2015 Akkina RK, Allam A, Balazs AB, Blankson J, Burnett JC, Casares S, Garcia JV, Hasenkrug K, Kashanchi F, Kitchen S, Klein F, Kumar P, Luster AD, Poluektova LY, Rao M, et al. Improvements and Limitations of Humanized Mouse Models for HIV Research: NIH/NIAID "Meet the Experts" 2015 Workshop Summary. Aids Research and Human Retroviruses. PMID 26670361 DOI: 10.1089/Aid.2015.0258  1
2015 Andersen IA, Huntley BK, Sandberg SS, Heublein DM, Burnett JC. Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 26666498 DOI: 10.1093/ndt/gfv398  1
2015 Saayman SM, Lazar DC, Scott TA, Hart JR, Takahashi M, Burnett JC, Planelles V, Morris KV, Weinberg MS. Potent and targeted activation of latent HIV-1 using the CRISPR/dCas9 activator complex. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26581162 DOI: 10.1038/Mt.2015.202  1
2015 Bellavia D, Cataliotti A, Clemenza F, Baravoglia CH, Luca A, Traina M, Gridelli B, Bertani T, Burnett JC, Scardulla C. Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study. Plos One. 10: e0142103. PMID 26556804 DOI: 10.1371/journal.pone.0142103  1
2015 Buglioni A, Burnett JC. New Pharmacological Strategies to Increase cGMP. Annual Review of Medicine. PMID 26473417 DOI: 10.1146/annurev-med-052914-091923  1
2015 Guo S, Goetze JP, Jeppesen JL, Burnett JC, Olesen J, Jansen-Olesen I, Ashina M. Effect of natriuretic peptides on cerebral artery blood flow in healthy volunteers. Peptides. PMID 26417835 DOI: 10.1016/J.Peptides.2015.09.008  1
2015 Ichiki T, Huntley BK, Sangaralingham SJ, Burnett JC. Pro-Atrial Natriuretic Peptide: A Novel Guanylyl Cyclase-A Receptor Activator That Goes Beyond Atrial and B-Type Natriuretic Peptides. Jacc. Heart Failure. 3: 715-23. PMID 26362447 DOI: 10.1016/j.jchf.2015.03.015  1
2015 Petz LD, Burnett JC, Li H, Li S, Tonai R, Bakalinskaya M, Shpall EJ, Armitage S, Kurtzberg J, Regan DM, Clark P, Querol S, Gutman JA, Spellman SR, Gragert L, et al. Progress toward curing HIV infection with hematopoietic cell transplantation. Stem Cells and Cloning : Advances and Applications. 8: 109-16. PMID 26251620 DOI: 10.2147/SCCAA.S56050  1
2015 Huang Y, Ng XW, Lim SG, Chen HH, Burnett JC, Boey YC, Venkatraman SS. In vivo Evaluation of Cenderitide-Eluting Stent (CES) II. Annals of Biomedical Engineering. PMID 26178873 DOI: 10.1007/s10439-015-1389-1  1
2015 Holditch SJ, Schreiber CA, Nini R, Tonne JM, Peng KW, Geurts A, Jacob HJ, Burnett JC, Cataliotti A, Ikeda Y. B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension. Hypertension. 66: 199-210. PMID 26063669 DOI: 10.1161/Hypertensionaha.115.05610  1
2015 Kiris E, Nuss JE, Stanford SM, Wanner LM, Cazares L, Maestre MF, Du HT, Gomba GY, Burnett JC, Gussio R, Bottini N, Panchal RG, Kane CD, Tessarollo L, Bavari S. Phosphatase Inhibitors Function as Novel, Broad Spectrum Botulinum Neurotoxin Antagonists in Mouse and Human Embryonic Stem Cell-Derived Motor Neuron-Based Assays. Plos One. 10: e0129264. PMID 26061731 DOI: 10.1371/Journal.Pone.0129264  1
2015 Bobbin ML, Burnett JC, Rossi JJ. RNA interference approaches for treatment of HIV-1 infection. Genome Medicine. 7: 50. PMID 26019725 DOI: 10.1186/S13073-015-0174-Y  1
2015 Sangaralingham SJ, McKie PM, Ichiki T, Scott CG, Heublein DM, Chen HH, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC. Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population. Hypertension. 65: 1187-94. PMID 25895587 DOI: 10.1161/Hypertensionaha.115.05366  1
2015 Miller WL, Borgeson DD, Grantham JA, Luchner A, Redfield MM, Burnett JC. Dietary sodium modulation of aldosterone activation and renal function during the progression of experimental heart failure. European Journal of Heart Failure. 17: 144-50. PMID 25823360 DOI: 10.1002/ejhf.212  1
2015 Kiris E, Burnett JC, Nuss JE, Wanner LM, Peyser BD, Du HT, Gomba GY, Kota KP, Panchal RG, Gussio R, Kane CD, Tessarollo L, Bavari S. SRC family kinase inhibitors antagonize the toxicity of multiple serotypes of botulinum neurotoxin in human embryonic stem cell-derived motor neurons. Neurotoxicity Research. 27: 384-98. PMID 25782580 DOI: 10.1007/S12640-015-9526-Z  1
2015 Takahashi M, Burnett JC, Rossi JJ. Aptamer-siRNA chimeras for HIV. Advances in Experimental Medicine and Biology. 848: 211-34. PMID 25757623 DOI: 10.1007/978-1-4939-2432-5_11  1
2015 Zhou J, Satheesan S, Li H, Weinberg MS, Morris KV, Burnett JC, Rossi JJ. Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity. Chemistry & Biology. 22: 379-90. PMID 25754473 DOI: 10.1016/J.Chembiol.2015.01.005  1
2015 Arora P, Reingold J, Baggish A, Guanaga DP, Wu C, Ghorbani A, Song Y, Chen-Tournaux A, Khan AM, Tainsh LT, Buys ES, Williams JS, Heublein DM, Burnett JC, Semigran MJ, et al. Weight loss, saline loading, and the natriuretic peptide system. Journal of the American Heart Association. 4: e001265. PMID 25595796 DOI: 10.1161/Jaha.114.001265  1
2015 Zakeri R, Burnett JC, Sangaralingham SJ. Urinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling. Clinica Chimica Acta; International Journal of Clinical Chemistry. 443: 108-13. PMID 25512164 DOI: 10.1016/j.cca.2014.12.009  1
2015 Fiuzat M, Burnett JC. Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling. Jacc. Heart Failure. 3: 68-9. PMID 25458173 DOI: 10.1016/j.jchf.2014.10.003  1
2015 Pereira NL, Tosakulwong N, Scott CG, Jenkins GD, Prodduturi N, Chai Y, Olson TM, Rodeheffer RJ, Redfield MM, Weinshilboum RM, Burnett JC. Circulating atrial natriuretic peptide genetic association study identifies a novel gene cluster associated with stroke in whites. Circulation. Cardiovascular Genetics. 8: 141-9. PMID 25452597 DOI: 10.1161/CIRCGENETICS.114.000624  1
2015 Buglioni A, Burnett JC. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators. Clinica Chimica Acta; International Journal of Clinical Chemistry. 443: 3-8. PMID 25445413 DOI: 10.1016/j.cca.2014.10.027  1
2015 Buglioni A, Cannone V, Cataliotti A, Sangaralingham SJ, Heublein DM, Scott CG, Bailey KR, Rodeheffer RJ, Dessì-Fulgheri P, Sarzani R, Burnett JC. Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease. Hypertension. 65: 45-53. PMID 25368032 DOI: 10.1161/HYPERTENSIONAHA.114.03936  1
2015 Huntley BK, Sandberg SM, Heublein DM, Sangaralingham SJ, Burnett JC, Ichiki T. Pro-B-type natriuretic peptide-1-108 processing and degradation in human heart failure. Circulation. Heart Failure. 8: 89-97. PMID 25339504 DOI: 10.1161/CIRCHEARTFAILURE.114.001174  1
2015 McKie PM, Burnett JC. Rationale and therapeutic opportunities for natriuretic peptide system augmentation in heart failure. Current Heart Failure Reports. 12: 7-14. PMID 25331110 DOI: 10.1007/s11897-014-0235-3  1
2015 Pereira NL, Tosakulwong N, Scott CG, Jenkins GD, Prodduturi N, Chai Y, Olson TM, Rodeheffer RJ, Redfield MM, Weinshilboum RM, Burnett JC. Circulating atrial natriuretic peptide genetic association study identifies a novel gene cluster associated with stroke in whites Circulation: Cardiovascular Genetics. 8: 141-149. DOI: 10.1161/CIRCGENETICS.114.000624  1
2015 Jung U, Castanotto D, Jung M, Burnett J, Rossi JJ. 692. A Novel RNAi Trigger Design Retains Potent, Target Specific Activity Despite Emerging Mutations in the Target Site Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)34301-5  1
2015 Takahashi M, Zhou J, Burnett JC, Rossi JJ. 581. Exploring Potency of Small RNAs for HIV Latency Reactivation Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)34190-9  1
2015 Satheesan S, Li H, Takahashi M, Zhou J, Burnett J, Rossi JJ. 580. In Vivo Analyses of Aptamers and siRNA Therapeutics Against HIV-1 in Humanized Mouse Model Molecular Therapy. 23. DOI: 10.1016/S1525-0016(16)34189-2  1
2014 Pan S, Chen HH, Correia C, Dai H, Witt TA, Kleppe LS, Burnett JC, Simari RD. Cell surface protein disulfide isomerase regulates natriuretic peptide generation of cyclic guanosine monophosphate. Plos One. 9: e112986. PMID 25419565 DOI: 10.1371/journal.pone.0112986  1
2014 Zhang X, Li H, Burnett JC, Rossi JJ. The role of antisense long noncoding RNA in small RNA-triggered gene activation. Rna (New York, N.Y.). 20: 1916-28. PMID 25344398 DOI: 10.1261/Rna.043968.113  1
2014 Kiris E, Burnett JC, Kane CD, Bavari S. Recent advances in botulinum neurotoxin inhibitor development. Current Topics in Medicinal Chemistry. 14: 2044-61. PMID 25335887 DOI: 10.2174/1568026614666141022093350  1
2014 Ichiki T, Burnett JC. Post-transcriptional modification of pro-BNP in heart failure: is glycosylation and circulating furin key for cardiovascular homeostasis? European Heart Journal. 35: 3001-3. PMID 25246481 DOI: 10.1093/eurheartj/ehu381  1
2014 Ng XW, Huang Y, Liu KL, Lim SG, Chen HH, Burnett JC, Freddy Boey YC, Venkatraman SS. In vitro evaluation of cenderitide-eluting stent I -an antirestenosis and proendothelization approach. Journal of Pharmaceutical Sciences. 103: 3631-40. PMID 25223419 DOI: 10.1002/jps.24165  1
2014 Cannone V, Barlera S, Pileggi S, Masson S, Franzosi MG, Latini R, Scardulla C, Clemenza F, Maggioni AP, Nicolosi GL, Tavazzi L, Burnett JC. The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure. International Journal of Cardiology. 176: 1249-51. PMID 25129277 DOI: 10.1016/j.ijcard.2014.07.200  1
2014 Ichiki T, Schirger JA, Huntley BK, Brozovich FV, Maleszewski JJ, Sandberg SM, Sangaralingham SJ, Park SJ, Burnett JC. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications. Journal of Molecular and Cellular Cardiology. 75: 199-205. PMID 25117468 DOI: 10.1016/j.yjmcc.2014.08.001  1
2014 McKie PM, AbouEzzeddine OF, Scott CG, Mehta R, Rodeheffer RJ, Redfield MM, Burnett JC, Jaffe AS. High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population. Clinical Chemistry. 60: 1225-33. PMID 24987112 DOI: 10.1373/clinchem.2014.222778  1
2014 Chadalavada D, Adamson TW, Burnett JC, Chen RW, Rossi JJ. Irradiated compared with nonirradiated NSG mice for the development of a human B-cell lymphoma model. Comparative Medicine. 64: 179-85. PMID 24956209  1
2014 Videnović M, Opsenica DM, Burnett JC, Gomba L, Nuss JE, Selaković Z, Konstantinović J, Krstić M, Segan S, Zlatović M, Sciotti RJ, Bavari S, Solaja BA. Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria. Journal of Medicinal Chemistry. 57: 4134-53. PMID 24742203 DOI: 10.1021/Jm500033R  1
2014 Gruson D, Buglioni A, Burnett JC. PTH: Potential role in management of heart failure. Clinica Chimica Acta; International Journal of Clinical Chemistry. 433: 290-6. PMID 24704306 DOI: 10.1016/j.cca.2014.03.029  1
2014 Salamoun J, Anderson S, Burnett JC, Gussio R, Wipf P. Synthesis of heterocyclic triads by Pd-catalyzed cross-couplings and evaluation of their cell-specific toxicity profile. Organic Letters. 16: 2034-7. PMID 24641272 DOI: 10.1021/Ol500620M  1
2014 Pereira NL, Redfield MM, Scott C, Tosakulwong N, Olson TM, Bailey KR, Rodeheffer RJ, Burnett JC. A functional genetic variant (N521D) in natriuretic peptide receptor 3 is associated with diastolic dysfunction: the prevalence of asymptomatic ventricular dysfunction study. Plos One. 9: e85708. PMID 24465655 DOI: 10.1371/Journal.Pone.0085708  1
2014 Kiris E, Kota KP, Burnett JC, Soloveva V, Kane CD, Bavari S. Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery. Expert Review of Molecular Diagnostics. 14: 153-68. PMID 24450833 DOI: 10.1586/14737159.2014.867808  1
2014 McKie PM, Cataliotti A, Ichiki T, Sangaralingham SJ, Chen HH, Burnett JC. M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics. Journal of the American Heart Association. 3: e000206. PMID 24385449 DOI: 10.1161/JAHA.113.000206  1
2014 Zhou J, Ding Y, Burnett JC, Rossi J. Retroviruses for Cancer Therapy Cancer Gene Therapy by Viral and Non-Viral Vectors. 21-38. DOI: 10.1002/9781118501665.ch2  1
2014 Puccia G, Cannone V, McKie PM, Burnett JC. MANP: A novel designer natriuretic peptide GC-A activator for the treatment of hypertension and heart failure Natriuretic Peptides: Physiology, Molecular Biology, and Clinical Implications. 77-100.  1
2013 Costello-Boerrigter LC, Lapp H, Boerrigter G, Lerman A, Bufe A, Macheret F, Heublein DM, Larue C, Burnett JC. Secretion of prohormone of B-type natriuretic peptide, proBNP1-108, is increased in heart failure. Jacc. Heart Failure. 1: 207-12. PMID 24621871 DOI: 10.1016/j.jchf.2013.03.001  1
2013 Greene SJ, Gheorghiade M, Borlaug BA, Pieske B, Vaduganathan M, Burnett JC, Roessig L, Stasch JP, Solomon SD, Paulus WJ, Butler J. The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. Journal of the American Heart Association. 2: e000536. PMID 24334823 DOI: 10.1161/JAHA.113.000536  1
2013 Zakeri R, Sangaralingham SJ, Sandberg SM, Heublein DM, Scott CG, Burnett JC. Urinary C-type natriuretic peptide: a new heart failure biomarker. Jacc. Heart Failure. 1: 170-7. PMID 24244916 DOI: 10.1016/j.jchf.2012.12.003  1
2013 Cannone V, Huntley BK, Olson TM, Heublein DM, Scott CG, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC. Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study. Hypertension. 62: 860-5. PMID 24041948 DOI: 10.1161/Hypertensionaha.113.01344  1
2013 Ichiki T, Huntley BK, Burnett JC. BNP molecular forms and processing by the cardiac serine protease corin. Advances in Clinical Chemistry. 61: 1-31. PMID 24015598 DOI: 10.1016/B978-0-12-407680-8.00001-4  1
2013 Ouellet DL, Vigneault-Edwards J, Létourneau K, Gobeil LA, Plante I, Burnett JC, Rossi JJ, Provost P. Regulation of host gene expression by HIV-1 TAR microRNAs. Retrovirology. 10: 86. PMID 23938024 DOI: 10.1186/1742-4690-10-86  1
2013 Ichiki T, Izumi R, Cataliotti A, Larsen AM, Sandberg SM, Burnett JC. Endothelial permeability in vitro and in vivo: protective actions of ANP and omapatrilat in experimental atherosclerosis. Peptides. 48: 21-6. PMID 23927843 DOI: 10.1016/j.peptides.2013.07.020  1
2013 Sangaralingham SJ, Burnett JC, McKie PM, Schirger JA, Chen HH. Rationale and design of a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of B-type natriuretic peptide for the preservation of left ventricular function after anterior myocardial infarction. Journal of Cardiac Failure. 19: 533-9. PMID 23910581 DOI: 10.1016/j.cardfail.2013.06.002  1
2013 Ng XW, Huang Y, Chen HH, Burnett JC, Boey FY, Venkatraman SS. Cenderitide-eluting film for potential cardiac patch applications. Plos One. 8: e68346. PMID 23861890 DOI: 10.1371/journal.pone.0068346  1
2013 Opsenica IM, Tot M, Gomba L, Nuss JE, Sciotti RJ, Bavari S, Burnett JC, Solaja BA. 4-Amino-7-chloroquinolines: probing ligand efficiency provides botulinum neurotoxin serotype A light chain inhibitors with significant antiprotozoal activity. Journal of Medicinal Chemistry. 56: 5860-71. PMID 23815186 DOI: 10.1021/Jm4006077  1
2013 dos Santos Edos A, Hamel E, Bai R, Burnett JC, Tozatti CS, Bogo D, Perdomo RT, Antunes AM, Marques MM, Matos Mde F, de Lima DP. Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity. Bioorganic & Medicinal Chemistry Letters. 23: 4669-73. PMID 23810282 DOI: 10.1016/J.Bmcl.2013.06.009  1
2013 von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC, Krum H. Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure. Circulation. Heart Failure. 6: 594-605. PMID 23694773 DOI: 10.1161/CIRCHEARTFAILURE.112.000289  1
2013 Zhou J, Shum KT, Burnett JC, Rossi JJ. Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges. Pharmaceuticals (Basel, Switzerland). 6: 85-107. PMID 23667320 DOI: 10.3390/Ph6010085  1
2013 Buglioni A, Burnett JC. A gut-heart connection in cardiometabolic regulation. Nature Medicine. 19: 534-6. PMID 23652101 DOI: 10.1038/nm.3196  1
2013 Cannone V, Cefalu' AB, Noto D, Scott CG, Bailey KR, Cavera G, Pagano M, Sapienza M, Averna MR, Burnett JC. The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population. Diabetes Care. 36: 2850-6. PMID 23637347 DOI: 10.2337/Dc12-2337  1
2013 Snead NM, Wu X, Li A, Cui Q, Sakurai K, Burnett JC, Rossi JJ. Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants. Nucleic Acids Research. 41: 6209-21. PMID 23620279 DOI: 10.1093/Nar/Gkt200  1
2013 McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ, Redfield MM, Burnett JC, Jaffe AS. Defining high-sensitivity cardiac troponin concentrations in the community. Clinical Chemistry. 59: 1099-107. PMID 23592511 DOI: 10.1373/clinchem.2012.198614  1
2013 Violin JD, Soergel DG, Boerrigter G, Burnett JC, Lark MW. GPCR biased ligands as novel heart failure therapeutics. Trends in Cardiovascular Medicine. 23: 242-9. PMID 23499300 DOI: 10.1016/j.tcm.2013.01.002  1
2013 Pereira NL, Lin D, Pelleymounter L, Moon I, Stilling G, Eckloff BW, Wieben ED, Redfield MM, Burnett JC, Yee VC, Weinshilboum RM. Natriuretic peptide receptor-3 gene (NPR3): nonsynonymous polymorphism results in significant reduction in protein expression because of accelerated degradation. Circulation. Cardiovascular Genetics. 6: 201-10. PMID 23493048 DOI: 10.1161/Circgenetics.112.964742  1
2013 Zhou J, Tiemann K, Chomchan P, Alluin J, Swiderski P, Burnett J, Zhang X, Forman S, Chen R, Rossi J. Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells. Nucleic Acids Research. 41: 4266-83. PMID 23470998 DOI: 10.1093/Nar/Gkt125  1
2013 Lim SG, Venkatraman SS, Burnett JC, Chen HH. In-vivo evaluation of an in situ polymer precipitation delivery system for a novel natriuretic peptide. Plos One. 8: e52484. PMID 23441143 DOI: 10.1371/journal.pone.0052484  1
2013 Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, Maggioni AP, Cook T, Swedberg K, Burnett JC, Grinfeld L, Udelson JE, Zannad F, Gheorghiade M. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. European Heart Journal. 34: 835-43. PMID 23293303 DOI: 10.1093/Eurheartj/Ehs444  1
2013 Ichiki T, Boerrigter G, Huntley BK, Sangaralingham SJ, McKie PM, Harty GJ, Harders GE, Burnett JC. Differential expression of the pro-natriuretic peptide convertases corin and furin in experimental heart failure and atrial fibrosis. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 304: R102-9. PMID 23152112 DOI: 10.1152/ajpregu.00233.2012  1
2013 Mangiafico S, Costello-Boerrigter LC, Andersen IA, Cataliotti A, Burnett JC. Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics. European Heart Journal. 34: 886-893c. PMID 22942338 DOI: 10.1093/eurheartj/ehs262  1
2013 Gheorghiade M, Marti CN, Sabbah HN, Roessig L, Greene SJ, Böhm M, Burnett JC, Campia U, Cleland JG, Collins SP, Fonarow GC, Levy PD, Metra M, Pitt B, Ponikowski P, et al. Soluble guanylate cyclase: a potential therapeutic target for heart failure. Heart Failure Reviews. 18: 123-34. PMID 22622468 DOI: 10.1007/S10741-012-9323-1  1
2013 Tot M, Opsenica DM, Mitrić M, Burnett JC, Gomba L, Bavari S, Šolaja BA. New 9-aminoacridine derivatives as inhibitors of botulinum neurotoxins and P. falciparum malaria Journal of the Serbian Chemical Society. 78: 1847-1864. DOI: 10.2298/Jsc130924112T  1
2012 Martin FL, Sangaralingham SJ, Huntley BK, McKie PM, Ichiki T, Chen HH, Korinek J, Harders GE, Burnett JC. CD-NP: a novel engineered dual guanylyl cyclase activator with anti-fibrotic actions in the heart. Plos One. 7: e52422. PMID 23272242 DOI: 10.1371/journal.pone.0052422  1
2012 Ichiki T, Burnett JC. Protein therapeutics for cardiovascular disease: it is all about delivery. Journal of the American College of Cardiology. 60: 2558-60. PMID 23158538 DOI: 10.1016/j.jacc.2012.09.026  1
2012 Zhou J, Bobbin ML, Burnett JC, Rossi JJ. Current progress of RNA aptamer-based therapeutics. Frontiers in Genetics. 3: 234. PMID 23130020 DOI: 10.3389/Fgene.2012.00234  1
2012 Chen HH, Glockner JF, Schirger JA, Cataliotti A, Redfield MM, Burnett JC. Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide. Journal of the American College of Cardiology. 60: 2305-12. PMID 23122795 DOI: 10.1016/j.jacc.2012.07.056  1
2012 Selaković Z, Opsenica D, Eaton B, Retterer C, Bavari S, Burnett JC, Solaja BA, Panchal RG. A limited structural modification results in a significantly more efficacious diazachrysene-based filovirus inhibitor. Viruses. 4: 1279-88. PMID 23012625 DOI: 10.3390/V4081279  1
2012 Burnett JC, Zaia JA, Rossi JJ. Creating genetic resistance to HIV. Current Opinion in Immunology. 24: 625-32. PMID 22985479 DOI: 10.1016/J.Coi.2012.08.013  1
2012 Boerrigter G, Soergel DG, Violin JD, Lark MW, Burnett JC. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure. Circulation. Heart Failure. 5: 627-34. PMID 22891045 DOI: 10.1161/CIRCHEARTFAILURE.112.969220  1
2012 Sangaralingham SJ, Ritman EL, McKie PM, Ichiki T, Lerman A, Scott CG, Martin FL, Harders GE, Bellavia D, Burnett JC. Cardiac micro-computed tomography imaging of the aging coronary vasculature. Circulation. Cardiovascular Imaging. 5: 518-24. PMID 22679058 DOI: 10.1161/CIRCIMAGING.112.973057  1
2012 Vaduganathan M, Gheorghiade M, Pang PS, Konstam MA, Zannad F, Swedberg K, Grinfeld L, Burnett JC, Krasa HB, Zimmer C, Blair J, Ouyang J, Maggioni AP. Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment. Journal of Cardiovascular Medicine (Hagerstown, Md.). 13: 415-22. PMID 22673023 DOI: 10.2459/JCM.0b013e328355a740  1
2012 Opsenica I, Filipovic V, Nuss JE, Gomba LM, Opsenica D, Burnett JC, Gussio R, Solaja BA, Bavari S. The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease. European Journal of Medicinal Chemistry. 53: 374-9. PMID 22516424 DOI: 10.1016/J.Ejmech.2012.03.043  1
2012 Cataliotti A, Costello-Boerrigter LC, Chen HH, Textor SC, Burnett JC. Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension. Mayo Clinic Proceedings. 87: 413-5. PMID 22469356 DOI: 10.1016/j.mayocp.2012.02.003  1
2012 Greenberg BH, Anand IS, Burnett JC, Chin J, Dracup KA, Feldman AM, Force T, Francis GS, Houser SR, Hunt SA, Konstam MA, Lindenfeld J, Mann DL, Mehra MR, Paul SC, et al. The Heart Failure Society of America in 2020: a vision for the future. Journal of Cardiac Failure. 18: 90-3. PMID 22300775 DOI: 10.1016/J.Cardfail.2011.12.008  1
2012 Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chemistry & Biology. 19: 60-71. PMID 22284355 DOI: 10.1016/J.Chembiol.2011.12.008  1
2012 Dey SS, Xue Y, Joachimiak MP, Friedland GD, Burnett JC, Zhou Q, Arkin AP, Schaffer DV. Mutual information analysis reveals coevolving residues in Tat that compensate for two distinct functions in HIV-1 gene expression. The Journal of Biological Chemistry. 287: 7945-55. PMID 22253435 DOI: 10.1074/Jbc.M111.302653  1
2012 McKie PM, Ichiki T, Burnett JC. M-atrial natriuretic peptide: a novel antihypertensive protein therapy. Current Hypertension Reports. 14: 62-9. PMID 22135207 DOI: 10.1007/s11906-011-0244-5  1
2012 Martin FL, McKie PM, Cataliotti A, Sangaralingham SJ, Korinek J, Huntley BK, Oehler EA, Harders GE, Ichiki T, Mangiafico S, Nath KA, Redfield MM, Chen HH, Burnett JC. Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 302: R292-9. PMID 22071162 DOI: 10.1152/ajpregu.00194.2011  1
2012 Mohammed SF, Storlie JR, Oehler EA, Bowen LA, Korinek J, Lam CS, Simari RD, Burnett JC, Redfield MM. Variable phenotype in murine transverse aortic constriction. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 21: 188-98. PMID 21764606 DOI: 10.1016/j.carpath.2011.05.002  1
2012 Kousholt BS, Larsen JKR, Bisgaard L, Burnett JC, Hasenkam JM, Goetze JP. Natriuretic peptide infusion reduces myocardial injury during acute ischemia/reperfusion Cardiovascular Endocrinology. 1: 4-12. DOI: 10.1097/XCE.0b013e328356c67b  1
2011 Bishu K, Hamdani N, Mohammed SF, Kruger M, Ohtani T, Ogut O, Brozovich FV, Burnett JC, Linke WA, Redfield MM. Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo. Circulation. 124: 2882-91. PMID 22144574 DOI: 10.1161/Circulationaha.111.048520  1
2011 McKie PM, Cataliotti A, Sangaralingham SJ, Ichiki T, Cannone V, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC. Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study. Mayo Clinic Proceedings. 86: 1154-60. PMID 22134933 DOI: 10.4065/Mcp.2011.0437  1
2011 Costello-Boerrigter LC, Burnett JC. Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis. Journal of Cardiac Failure. 17: 990-2. PMID 22123360 DOI: 10.1016/j.cardfail.2011.10.002  1
2011 Ruthel G, Burnett JC, Nuss JE, Wanner LM, Tressler LE, Torres-Melendez E, Sandwick SJ, Retterer CJ, Bavari S. Post-intoxication inhibition of botulinum neurotoxin serotype A within neurons by small-molecule, non-peptidic inhibitors. Toxins. 3: 207-17. PMID 22069707 DOI: 10.3390/Toxins3030207  1
2011 McKie PM, Schirger JA, Costello-Boerrigter LC, Benike SL, Harstad LK, Bailey KR, Hodge DO, Redfield MM, Simari RD, Burnett JC, Chen HH. Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction. Journal of the American College of Cardiology. 58: 2095-103. PMID 22051332 DOI: 10.1016/J.Jacc.2011.07.042  1
2011 Sangaralingham SJ, Heublein DM, Grande JP, Cataliotti A, Rule AD, McKie PM, Martin FL, Burnett JC. Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging. American Journal of Physiology. Renal Physiology. 301: F943-52. PMID 21865266 DOI: 10.1152/ajprenal.00170.2011  1
2011 Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC, Jacobsen SJ, Rodeheffer RJ. Progression of left ventricular diastolic dysfunction and risk of heart failure. Jama. 306: 856-63. PMID 21862747 DOI: 10.1001/jama.2011.1201  1
2011 Boerrigter G, Burnett JC. Natriuretic peptides renal protective after all? Journal of the American College of Cardiology. 58: 904-6. PMID 21851877 DOI: 10.1016/j.jacc.2010.12.053  1
2011 Boerrigter G, Lark MW, Whalen EJ, Soergel DG, Violin JD, Burnett JC. Cardiorenal actions of TRV120027, a novel ß-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure. Circulation. Heart Failure. 4: 770-8. PMID 21835984 DOI: 10.1161/Circheartfailure.111.962571  1
2011 Zakeri R, Burnett JC. Designer natriuretic peptides: a vision for the future of heart failure therapeutics. Canadian Journal of Physiology and Pharmacology. 89: 593-601. PMID 21815778 DOI: 10.1139/y11-048  1
2011 Cannone V, Boerrigter G, Cataliotti A, Costello-Boerrigter LC, Olson TM, McKie PM, Heublein DM, Lahr BD, Bailey KR, Averna M, Redfield MM, Rodeheffer RJ, Burnett JC. A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community. Journal of the American College of Cardiology. 58: 629-36. PMID 21798427 DOI: 10.1016/J.Jacc.2011.05.011  1
2011 Blair JE, Pang PS, Schrier RW, Metra M, Traver B, Cook T, Campia U, Ambrosy A, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Konstam MA, et al. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. European Heart Journal. 32: 2563-72. PMID 21785107 DOI: 10.1093/Eurheartj/Ehr238  1
2011 Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnology Journal. 6: 1130-46. PMID 21744502 DOI: 10.1002/Biot.201100054  1
2011 Pang PS, Gheorghiade M, Dihu J, Swedberg K, Khan S, Maggioni AP, Grinfeld L, Zannad F, Burnett JC, Ouyang J, Udelson JE, Konstam MA. Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trials. American Heart Journal. 161: 1067-72. PMID 21641352 DOI: 10.1016/j.ahj.2011.02.027  1
2011 Costello-Boerrigter LC, Burnett JC. Heart failure: furosemide--to DOSE or not to DOSE, that is the question. Nature Reviews. Cardiology. 8: 365-6. PMID 21629212 DOI: 10.1038/nrcardio.2011.74  1
2011 Bai R, Nguyen TL, Burnett JC, Atasoylu O, Munro MH, Pettit GR, Smith AB, Gussio R, Hamel E. Interactions of halichondrin B and eribulin with tubulin. Journal of Chemical Information and Modeling. 51: 1393-404. PMID 21539396 DOI: 10.1021/Ci200077T  1
2011 Tonne JM, Campbell JM, Cataliotti A, Ohmine S, Thatava T, Sakuma T, Macheret F, Huntley BK, Burnett JC, Ikeda Y. Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes. Clinical Chemistry. 57: 864-73. PMID 21482747 DOI: 10.1373/Clinchem.2010.157438  1
2011 Macheret F, Boerrigter G, McKie P, Costello-Boerrigter L, Lahr B, Heublein D, Sandberg S, Ikeda Y, Cataliotti A, Bailey K, Rodeheffer R, Burnett JC. Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction. Journal of the American College of Cardiology. 57: 1386-95. PMID 21414536 DOI: 10.1016/J.Jacc.2011.01.005  1
2011 Cataliotti A, Tonne JM, Bellavia D, Martin FL, Oehler EA, Harders GE, Campbell JM, Peng KW, Russell SJ, Malatino LS, Burnett JC, Ikeda Y. Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats. Circulation. 123: 1297-305. PMID 21403100 DOI: 10.1161/Circulationaha.110.981720  1
2011 Cannone V, McKie PM, Burnett JC. Can a cardiac peptide predict mortality in human hypertension? Hypertension. 57: 670-1. PMID 21383309 DOI: 10.1161/HYPERTENSIONAHA.110.168609  1
2011 Costello-Boerrigter LC, Boerrigter G, Ameenuddin S, Mahoney DW, Slusser JP, Heublein DM, Redfield MM, Rodeheffer RJ, Olson TM, Burnett JC. The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays. Mayo Clinic Proceedings. 86: 210-8. PMID 21364112 DOI: 10.4065/mcp.2010.0708  1
2011 Kiris E, Nuss JE, Burnett JC, Kota KP, Koh DC, Wanner LM, Torres-Melendez E, Gussio R, Tessarollo L, Bavari S. Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Research. 6: 195-205. PMID 21353660 DOI: 10.1016/J.Scr.2011.01.002  1
2011 Dong YX, Burnett JC, Chen HH, Sandberg S, Yang YZ, Zhang Y, Chen PS, Cha YM. Effect of cardiac resynchronization therapy on broad neurohormone biomarkers in heart failure. Journal of Interventional Cardiac Electrophysiology : An International Journal of Arrhythmias and Pacing. 30: 241-9. PMID 21336616 DOI: 10.1007/s10840-011-9551-7  1
2011 Bellavia D, Abraham RS, Pellikka PA, Dispenzieri A, Burnett JC, Al-Zahrani GB, Green TD, Manske MK, Gertz MA, Miller FA, Abraham TP. Utility of Doppler myocardial imaging, cardiac biomarkers, and clonal immunoglobulin genes to assess left ventricular performance and stratify risk following peripheral blood stem cell transplantation in patients with systemic light chain amyloidosis (Al). Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 24: 444-54. PMID 21315556 DOI: 10.1016/j.echo.2011.01.003  1
2011 Opsenica I, Burnett JC, Gussio R, Opsenica D, Todorović N, Lanteri CA, Sciotti RJ, Gettayacamin M, Basilico N, Taramelli D, Nuss JE, Wanner L, Panchal RG, Solaja BA, Bavari S. A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus. Journal of Medicinal Chemistry. 54: 1157-69. PMID 21265542 DOI: 10.1021/Jm100938U  1
2011 Li B, Peet NP, Butler MM, Burnett JC, Moir DT, Bowlin TL. Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication. Molecules (Basel, Switzerland). 16: 202-20. PMID 21193845 DOI: 10.3390/Molecules16010202  1
2011 Sangaralingham SJ, Huntley BK, Martin FL, McKie PM, Bellavia D, Ichiki T, Harders GE, Chen HH, Burnett JC. The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide. Hypertension. 57: 201-7. PMID 21189408 DOI: 10.1161/HYPERTENSIONAHA.110.160796  1
2011 Burnett JC, Nguyen TL. Is stoichiometry a new metric for evaluating folded proteins? Journal of Biomolecular Structure & Dynamics. 28: 641-2; discussion 66. PMID 21142245 DOI: 10.1080/073911011010524973  1
2011 Ichiki T, Huntley BK, Heublein DM, Sandberg SM, McKie PM, Martin FL, Jougasaki M, Burnett JC. Corin is present in the normal human heart, kidney, and blood, with pro-B-type natriuretic peptide processing in the circulation. Clinical Chemistry. 57: 40-7. PMID 21075870 DOI: 10.1373/clinchem.2010.153908  1
2011 Costello-Boerrigter LC, Boerrigter G, Ameenuddin S, Mahoney DW, Slusser JP, Heublein DM, Redfield MM, Rodeheffer RJ, Olson TM, Burnett JC. The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays Mayo Clinic Proceedings. 86: 210-218. DOI: 10.4065/mcp.2010.0708  1
2011 Burnett JC, Carrasco V. Coordination and the provision of incentives to a common regulated firm International Journal of Industrial Organization. 29: 606-627. DOI: 10.1016/J.Ijindorg.2011.01.005  1
2011 Boerrigter G, Costello-Boerrigter L, Burnett JC. Alterations in Renal Function in Heart Failure Heart Failure. 291-299. DOI: 10.1016/B978-1-4160-5895-3.10018-X  1
2010 Nuss JE, Dong Y, Wanner LM, Ruthel G, Wipf P, Gussio R, Vennerstrom JL, Bavari S, Burnett JC. Pharmacophore Refinement Guides the Rational Design of Nanomolar-Range Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease. Acs Medicinal Chemistry Letters. 1: 301-305. PMID 21116458 DOI: 10.1021/Ml100056V  1
2010 Shuford CM, Hawkridge AM, Burnett JC, Muddiman DC. Utilizing spectral counting to quantitatively characterize tandem removal of abundant proteins (TRAP) in human plasma. Analytical Chemistry. 82: 10179-85. PMID 21090636 DOI: 10.1021/Ac102248D  1
2010 McKie PM, Cataliotti A, Boerrigter G, Chen HH, Sangaralingham SJ, Martin FL, Ichiki T, Burnett JC. A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension. Hypertension. 56: 1152-9. PMID 20975033 DOI: 10.1161/HYPERTENSIONAHA.110.159210  1
2010 Skupsky R, Burnett JC, Foley JE, Schaffer DV, Arkin AP. HIV promoter integration site primarily modulates transcriptional burst size rather than frequency. Plos Computational Biology. 6. PMID 20941390 DOI: 10.1371/Journal.Pcbi.1000952  1
2010 Pereira NL, Aksoy P, Moon I, Peng Y, Redfield MM, Burnett JC, Wieben ED, Yee VC, Weinshilboum RM. Natriuretic peptide pharmacogenetics: membrane metallo-endopeptidase (MME): common gene sequence variation, functional characterization and degradation. Journal of Molecular and Cellular Cardiology. 49: 864-74. PMID 20692264 DOI: 10.1016/J.Yjmcc.2010.07.020  1
2010 Kilic A, Rajapurohitam V, Sandberg SM, Zeidan A, Hunter JC, Said Faruq N, Lee CY, Burnett JC, Karmazyn M. A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway. Cardiovascular Research. 88: 434-42. PMID 20679416 DOI: 10.1093/cvr/cvq254  1
2010 Mohammed SF, Ohtani T, Korinek J, Lam CS, Larsen K, Simari RD, Valencik ML, Burnett JC, Redfield MM. Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects". Circulation. 122: 370-8. PMID 20625113 DOI: 10.1161/CIRCULATIONAHA.109.915215  1
2010 Zuniga JE, Hammill JT, Drory O, Nuss JE, Burnett JC, Gussio R, Wipf P, Bavari S, Brunger AT. Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A. Plos One. 5: e11378. PMID 20614028 DOI: 10.1371/Journal.Pone.0011378  1
2010 Ichiki T, Burnett JC. A new signal from B-type natriuretic peptide in ST-elevation myocardial infarction: what does it mean for B-type natriuretic peptide and innovative diagnostics? Circulation. 122: 229-32. PMID 20606114 DOI: 10.1161/CIRCULATIONAHA.110.966358  1
2010 McKie PM, Sangaralingham SJ, Burnett JC. CD-NP: An innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease Current Heart Failure Reports. 7: 93-99. PMID 20582736 DOI: 10.1007/s11897-010-0016-6  1
2010 Boilson BA, Larsen K, Harbuzariu A, Delacroix S, Korinek J, Froehlich H, Bailey KR, Scott CG, Shapiro BP, Boerrigter G, Chen HH, Redfield MM, Burnett JC, Simari RD. Regulation of circulating progenitor cells in left ventricular dysfunction. Circulation. Heart Failure. 3: 635-42. PMID 20573992 DOI: 10.1161/Circheartfailure.109.879437  1
2010 Huntley BK, Ichiki T, Sangaralingham SJ, Chen HH, Burnett JC. B-type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts Journal of Cellular Physiology. 225: 251-255. PMID 20506274 DOI: 10.1002/jcp.22253  1
2010 McKie PM, Cataliotti A, Lahr BD, Martin FL, Redfield MM, Bailey KR, Rodeheffer RJ, Burnett JC. The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. Journal of the American College of Cardiology. 55: 2140-7. PMID 20447539 DOI: 10.1016/J.Jacc.2010.01.031  1
2010 Burnett JC, Lim KI, Calafi A, Rossi JJ, Schaffer DV, Arkin AP. Combinatorial latency reactivation for HIV-1 subtypes and variants. Journal of Virology. 84: 5958-74. PMID 20357084 DOI: 10.1128/Jvi.00161-10  1
2010 Correa De Sa DD, Hodge DO, Slusser JP, Redfield MM, Simari RD, Burnett JC, Chen HH. Progression of preclinical diastolic dysfunction to the development of symptoms Heart. 96: 528-532. PMID 20350989 DOI: 10.1136/hrt.2009.177980  1
2010 Costello-Boerrigter LC, Boerrigter G, Cataliotti A, Harty GJ, Burnett JC. Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure Circulation: Heart Failure. 3: 412-419. PMID 20176717 DOI: 10.1161/CIRCHEARTFAILURE.109.916114  1
2010 Shuford CM, Comins DL, Whitten JL, Burnett JC, Muddiman DC. Improving limits of detection for B-type natriuretic peptide using PC-IDMS: an application of the ALiPHAT strategy. The Analyst. 135: 36-41. PMID 20024179 DOI: 10.1039/B919484C  1
2009 Boerrigter G, Costello-Boerrigter LC, Abraham WT, St John Sutton MG, Heublein DM, Kruger KM, Hill MR, McCullough PA, Burnett JC. Response to Cardiac Resynchronization Therapy Improves Renal Function. Importance of Forward and Backward Failure. Journal of Cardiac Failure. 15: 79-80. PMID 20617159 DOI: 10.1016/j.cardfail.2008.11.001  1
2009 Frye RL, Simari RD, Gersh BJ, Burnett JC, Brumm S, Myerle K, Jaffe AS, Holmes DR, Lerman A, Terzic A. Ethical issues in cardiovascular research involving humans Circulation. 120: 2113-2121. PMID 19933950 DOI: 10.1161/Circulationaha.107.752766  1
2009 McKie PM, Cataliotti A, Huntley BK, Martin FL, Olson TM, Burnett JC. A Human Atrial Natriuretic Peptide Gene Mutation Reveals a Novel Peptide With Enhanced Blood Pressure-Lowering, Renal-Enhancing, and Aldosterone-Suppressing Actions Journal of the American College of Cardiology. 54: 1024-1032. PMID 19729120 DOI: 10.1016/j.jacc.2009.04.080  1
2009 Burnett JC, Wang C, Nuss JE, Nguyen TL, Hermone AR, Schmidt JJ, Gussio R, Wipf P, Bavari S. Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease. Bioorganic & Medicinal Chemistry Letters. 19: 5811-3. PMID 19703771 DOI: 10.1016/J.Bmcl.2009.01.111  1
2009 Burnett JC, Rossi JJ. Autologous cell therapy for HIV: Stem cells, ribozymes and HIV Gene Therapy. 16: 1178-1179. PMID 19641534 DOI: 10.1038/Gt.2009.86  1
2009 Boerrigter G, Costello-Boerrigter LC, Burnett JC. Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure Heart Failure Clinics. 5: 501-514. PMID 19631175 DOI: 10.1016/j.hfc.2009.04.002  1
2009 Kizer JR, Krauser DG, Rodeheffer RJ, Burnett JC, Okin PM, Roman MJ, Umans JG, Best LG, Lee ET, Devereux RB. Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study). The American Journal of Cardiology. 104: 247-53. PMID 19576355 DOI: 10.1016/J.Amjcard.2009.03.026  1
2009 Pang PS, Konstam MA, Krasa HB, Swedberg K, Zannad F, Blair JEA, Zimmer C, Teerlink JR, Maggioni AP, Burnett JC, Grinfeld L, Ouyang J, Udelson JE, Gheorghiade M. Effects of tolvaptan on dyspnoea relief from the EVEREST trials European Heart Journal. 30: 2233-2240. PMID 19561338 DOI: 10.1093/eurheartj/ehp253  1
2009 Pan S, Chen HH, Dickey DM, Boerrigter G, Lee C, Kleppe LS, Hall JL, Lerman A, Redfield MM, Potter LR, Burnett JC, Simari RD. Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide. Proceedings of the National Academy of Sciences of the United States of America. 106: 11282-7. PMID 19541613 DOI: 10.1073/Pnas.0811851106  1
2009 Miller WL, Burnett JC, Hartman KA, Hodge DO, Giuliani I, Minard F, Larue C, Jaffe AS. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide. Clinica Chimica Acta; International Journal of Clinical Chemistry. 406: 119-23. PMID 19523938 DOI: 10.1016/j.cca.2009.06.009  1
2009 Costello-Boerrigter LC, Burnett JC. A New Role for the Natriuretic Peptides. Metabolic Regulators of the Adipocyte Journal of the American College of Cardiology. 53: 2078-2079. PMID 19477359 DOI: 10.1016/j.jacc.2009.02.037  1
2009 Boerrigter G, Burnett JC. Soluble guanylate cyclase: Not a dull enzyme Circulation. 119: 2752-2754. PMID 19451346 DOI: 10.1161/CIRCULATIONAHA.109.860288  1
2009 Chen HH, Martin FL, Gibbons RJ, Schirger JA, Wright RS, Schears RM, Redfield MM, Simari RD, Lerman A, Cataliotti A, Burnett JC. Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: A proof of concept study Heart. 95: 1315-1319. PMID 19447837 DOI: 10.1136/hrt.2008.153916  1
2009 Blair JEA, Khan S, Konstam MA, Swedberg K, Zannad F, Burnett JC, Grinfeld L, Maggioni AP, Udelson JE, Zimmer CA, Ouyang J, Chen CF, Gheorghiade M. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial European Heart Journal. 30: 1666-1673. PMID 19411662 DOI: 10.1093/eurheartj/ehp144  1
2009 Lee CYW, Chen HH, Lisy O, Swan S, Cannon C, Lieu HD, Burnett JC. Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects Journal of Clinical Pharmacology. 49: 668-673. PMID 19395584 DOI: 10.1177/0091270009336233  1
2009 Boerrigter G, Costello-Boerrigter LC, Harty GJ, Huntley BK, Cataliotti A, Lapp H, Burnett JC. B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 296: R1744-50. PMID 19386989 DOI: 10.1152/ajpregu.00059.2009  1
2009 Chen HH, Cataliotti A, Schirger JA, Martin FL, Harstad LK, Burnett JC. Local Renal Delivery of a Natriuretic Peptide. A Renal-Enhancing Strategy for B-Type Natriuretic Peptide in Overt Experimental Heart Failure Journal of the American College of Cardiology. 53: 1302-1308. PMID 19358945 DOI: 10.1016/j.jacc.2009.01.030  1
2009 Andrews GL, Shuford CM, Burnett JC, Hawkridge AM, Muddiman DC. Coupling of a vented column with splitless nanoRPLC-ESI-MS for the improved separation and detection of brain natriuretic peptide-32 and its proteolytic peptides. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 877: 948-54. PMID 19269262 DOI: 10.1016/J.Jchromb.2009.02.040  1
2009 Burnett JC, Miller-Jensen K, Shah PS, Arkin AP, Schaffer DV. Control of stochastic gene expression by host factors at the HIV promoter. Plos Pathogens. 5: e1000260. PMID 19132086 DOI: 10.1371/Journal.Ppat.1000260  1
2009 Boerrigter G, Lapp H, Burnett JC. Modulation of cGMP in heart failure: a new therapeutic paradigm. Handbook of Experimental Pharmacology. 485-506. PMID 19089342 DOI: 10.1007/978-3-540-68964-5_21  1
2009 Miller WL, Hartman KA, Grill DE, Burnett JC, Jaffe AS. Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure. Clinical Chemistry. 55: 78-84. PMID 19028821 DOI: 10.1373/clinchem.2008.108928  1
2009 Costello-Boerrigter LC, Boerrigter G, Burnett JC. Pharmacology of vasopressin antagonists Heart Failure Reviews. 14: 75-82. PMID 18766438 DOI: 10.1007/s10741-008-9108-8  1
2009 Wang C, Widom J, Petronijevic F, Burnett JC, Nuss JE, Bavari S, Gussio R, Wipf P. Synthesis and biological evaluation of inhibitors of botulinum neurotoxin metalloprotease Heterocycles. 79: 487-520. DOI: 10.3987/Com-08-S(D)8  1
2008 Simari RD, Chen H, Burnett JC. The FDA and the new biology Journal of Cardiovascular Translational Research. 1: 246-247. PMID 20559929  1
2008 Burnett JC, Korinek J. The tumultuous journey of nesiritide: past, present, and future Circulation. Heart Failure. 1: 6-8. PMID 19808264  1
2008 Hermone AR, Burnett JC, Nuss JE, Tressler LE, Nguyen TL, Solaja BA, Vennerstrom JL, Schmidt JJ, Wipf P, Bavari S, Gussio R. Three-dimensional database mining identifies a unique chemotype that unites structurally diverse botulinum neurotoxin serotype A inhibitors in a three-zone pharmacophore. Chemmedchem. 3: 1905-12. PMID 19006141 DOI: 10.1002/Cmdc.200800241  1
2008 Leonard JN, Shah PS, Burnett JC, Schaffer DV. HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host & Microbe. 4: 484-94. PMID 18996348 DOI: 10.1016/J.Chom.2008.09.008  1
2008 Blair JEA, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M. Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure. Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program Journal of the American College of Cardiology. 52: 1640-1648. PMID 18992654 DOI: 10.1016/J.Jacc.2008.07.056  1
2008 Mohammed SF, Korinek J, Chen HH, Burnett JC, Redfield MM. Nesiritide in acute decompensated heart failure: Current status and future perspectives Reviews in Cardiovascular Medicine. 9: 151-158. PMID 18953274  1
2008 Dickey DM, Burnett JC, Potter LR. Novel bifunctional natriuretic peptides as potential therapeutics. The Journal of Biological Chemistry. 283: 35003-9. PMID 18940797 DOI: 10.1074/Jbc.M804538200  1
2008 Zuniga JE, Schmidt JJ, Fenn T, Burnett JC, Araç D, Gussio R, Stafford RG, Badie SS, Bavari S, Brunger AT. A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate. Structure (London, England : 1993). 16: 1588-97. PMID 18940613 DOI: 10.1016/J.Str.2008.07.011  1
2008 Cataliotti A, Chen HH, Schirger JA, Martin FL, Boerrigter G, Costello-Boerrigter LC, James KD, Polowy K, Miller MA, Malkar NB, Bailey KR, Burnett JC. Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension Circulation. 118: 1729-1736. PMID 18838565 DOI: 10.1161/Circulationaha.107.759241  1
2008 Korinek J, Boerrigter G, Mohammed SF, Burnett JC. Insights into natriuretic peptides in heart failure: An update Current Heart Failure Reports. 5: 97-104. PMID 18765080 DOI: 10.1007/s11897-008-0016-y  1
2008 Martin FL, Chen HH, Cataliotti A, Burnett JC. B-Type Natriuretic Peptide: Beyond a Diagnostic Heart Failure Clinics. 4: 449-454. PMID 18760756 DOI: 10.1016/j.hfc.2008.03.011  1
2008 Boerrigter G, Costello-Boerrigter LC, Abraham WT, Sutton MG, Heublein DM, Kruger KM, Hill MR, McCullough PA, Burnett JC. Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. Journal of Cardiac Failure. 14: 539-46. PMID 18722318 DOI: 10.1016/j.cardfail.2008.03.009  1
2008 Solaja BA, Opsenica D, Smith KS, Milhous WK, Terzić N, Opsenica I, Burnett JC, Nuss J, Gussio R, Bavari S. Novel 4-aminoquinolines active against chloroquine-resistant and sensitive P. falciparum strains that also inhibit botulinum serotype A. Journal of Medicinal Chemistry. 51: 4388-91. PMID 18637666 DOI: 10.1021/Jm800737Y  1
2008 Hodgson-Zingman DM, Karst ML, Zingman LV, Heublein DM, Darbar D, Herron KJ, Ballew JD, De Andrade M, Burnett JC, Olson TM. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation New England Journal of Medicine. 359: 158-165. PMID 18614783 DOI: 10.1056/NEJMoa0706300  1
2008 Lisy O, Huntley BK, McCormick DJ, Kurlansky PA, Burnett JC. Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NP Journal of the American College of Cardiology. 52: 60-68. PMID 18582636 DOI: 10.1016/j.jacc.2008.02.077  1
2008 Friedewald VE, Burnett JC, Januzzi JL, Roberts WC, Yancy CW. The Editor's Roundtable: B-Type Natriuretic Peptide American Journal of Cardiology. 101: 1733-1740. PMID 18549849 DOI: 10.1016/j.amjcard.2008.03.017  1
2008 Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC, Grinfeld L, Swedberg K, Udelson JE, Cook T, Traver B, Zimmer C, Orlandi C, Gheorghiade M. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. Jama. 299: 2656-66. PMID 18544725 DOI: 10.1001/Jama.299.22.2656  1
2008 Owan TE, Chen HH, Frantz RP, Karon BL, Miller WL, Rodeheffer RJ, Hodge DO, Burnett JC, Redfield MM. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction. Journal of Cardiac Failure. 14: 267-75. PMID 18474338 DOI: 10.1016/j.cardfail.2007.12.002  1
2008 Hawkridge AM, Muddiman DC, Hebulein DM, Cataliotti A, Burnett JC. Effect of plasma protein depletion on BNP-32 recovery. Clinical Chemistry. 54: 933-4. PMID 18443186 DOI: 10.1373/clinchem.2007.098038  1
2008 Martin FL, Chen HH, Cataliotti A, Burnett JC. Targeting the kidney in acute decompensated heart failure: Conventional diuretics and renal-acting vasodilators Reviews in Cardiovascular Medicine. 9: 39-45. PMID 18418308  1
2008 Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL. Biology of the Natriuretic Peptides American Journal of Cardiology. 101: S3-S8. PMID 18243856 DOI: 10.1016/j.amjcard.2007.11.012  1
2008 Shapiro BP, Owan TE, Mohammed S, Kruger M, Linke WA, Burnett JC, Redfield MM. Mineralocorticoid signaling in transition to heart failure with normal ejection fraction Hypertension. 51: 289-295. PMID 18086943 DOI: 10.1161/HYPERTENSIONAHA.107.099010  1
2008 Buchner S, Muscholl M, Debl K, Hense HW, Döring A, Stritzke J, Schunkert H, Jougasaki M, Burnett JC, Riegger GAJ, Luchner A. Left Atrial Size by Planimetry is Superior to M-mode Diameter: Biochemical Calibration by Atrial and Brain Natriuretic Peptide Journal of the American Society of Echocardiography. 21: 380-385. PMID 17681726 DOI: 10.1016/j.echo.2007.06.006  1
2008 Miller WL, Hartman KA, Grill DE, Burritt MF, Rodeheffer RJ, Burnett JC, Jaffe AS. Response to letter regarding article, "Serial biomarker measurements in ambulatory patients with chronic heart failure: The importance of change over time" Circulation. 117: e24. DOI: 10.1161/CIRCULATIONAHA.107.740936  1
2008 Lee CYW, Burnett JC. ANP, BNP and CNP: Physiology and Pharmacology of the Cardiorenal Axis Textbook of Nephro-Endocrinology. 287-307. DOI: 10.1016/B978-0-12-373870-7.00020-X  1
2008 Boerrigter G, Martin FL, Burnett JC. Kidney in acute heart failure Acute Heart Failure. 751-762. DOI: 10.1007/978-1-84628-782-4_68  1
2007 Costello-Boerrigter LC, Boerrigter G, Burnett JC. V2 receptor antagonism with tolvaptan in heart failure Expert Opinion On Investigational Drugs. 16: 1639-1647. PMID 17922627 DOI: 10.1517/13543784.16.10.1639  1
2007 Blair JEA, Manuchehry A, Chana A, Rossi J, Schrier RW, Burnett JC, Gheorghiade M. Prognostic markers in heart failure - Congestion, neurohormones, and the cardiorenal syndrome Acute Cardiac Care. 9: 207-213. PMID 17891672 DOI: 10.1080/17482940701606913  1
2007 Chen HH, Sundt TM, Cook DJ, Heublein DM, Burnett JC. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: A double-blind placebo-controlled pilot study Circulation. 116: I134-I138. PMID 17846293 DOI: 10.1161/CIRCULATIONAHA.106.697250  1
2007 Frantz RP, Lowes BD, Grayburn PA, White M, Krause-Steinrauf H, Krishnan V, Uyeda L, Burnett JC. Baseline and Serial Neurohormones in Patients With Congestive Heart Failure Treated With and Without Bucindolol: Results of the Neurohumoral Substudy of the Beta-Blocker Evaluation of Survival Study (BEST) Journal of Cardiac Failure. 13: 437-444. PMID 17675057 DOI: 10.1016/j.cardfail.2007.03.007  1
2007 Martin FL, Supaporn T, Chen HH, Sandberg SM, Matsuda Y, Jougasaki M, Burnett JC. Distinct roles for renal particulate and soluble guanylyl cyclases in preserving renal function in experimental acute heart failure American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 293: R1580-R1585. PMID 17670861 DOI: 10.1152/ajpregu.00284.2007  1
2007 Costello-Boerrigter LC, Boerrigter G, Harty GJ, Cataliotti A, Redfield MM, Burnett JC. Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction Hypertension. 50: 481-488. PMID 17635858 DOI: 10.1161/HYPERTENSIONAHA.107.088534  1
2007 Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC, Jaffe AS. Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation. 116: 249-57. PMID 17592074 DOI: 10.1161/CIRCULATIONAHA.107.694562  1
2007 Miller WL, Hartman KA, Burritt MF, Burnett JC, Jaffe AS. Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clinical Cardiology. 30: 245-50. PMID 17492679 DOI: 10.1002/clc.20075  1
2007 Lee CYW, Burnett JC. Natriuretic peptides and therapeutic applications Heart Failure Reviews. 12: 131-142. PMID 17440808 DOI: 10.1007/s10741-007-9016-3  1
2007 Burnett JC, Opsenica D, Sriraghavan K, Panchal RG, Ruthel G, Hermone AR, Nguyen TL, Kenny TA, Lane DJ, McGrath CF, Schmidt JJ, Vennerstrom JL, Gussio R, Solaja BA, Bavari S. A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease. Journal of Medicinal Chemistry. 50: 2127-36. PMID 17417831 DOI: 10.1021/Jm061446E  1
2007 Heublein D, Huntley B, Boerrigter G, Cataliotti A, Sandberg S, Redfield M, Burnett JC. Response to do commercially available assay kits for B-type natriuretic peptide measure pro-BNP1-108, as well as BNP1-32? [8] Hypertension. 50: e164. DOI: 10.1161/HYPERTENSIONAHA.107.098384  1
2007 Nguyen TL, Panchal RG, Topol IA, Lane D, Kenny T, Burnett JC, Hermone AR, McGrath C, Burt SK, Gussio R, Bavari S. A theoretical study of anthrax lethal factor inhibition by a set of novel carbamimidolyl-aryl-vinyl-carboxamidines: A possible mechanism involving zinc-ligation by amidine Journal of Molecular Structure: Theochem. 821: 139-144. DOI: 10.1016/J.Theochem.2007.07.009  1
2005 Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity. Cell. 122: 169-82. PMID 16051143 DOI: 10.1016/J.Cell.2005.06.006  1
2005 Weinberger LS, Burnett JC, Toettcher JE, Arkin AP, Schaffer DV. Stochastic gene expression in a lentiviral positive feedback loop: HIV-1 tat fluctuations drive phenotypic diversity Aiche Annual Meeting, Conference Proceedings. 10416.  1
Show low-probability matches.